Clare Brown

+61 2 8247 9643
+61 422 531 292


Clare specialises in corporate and public securities law, with a particular focus on equity capital markets.

She has experience in cross-border and domestic corporate transactions including advising on equity and hybrid security fundraisings, regulated and private M&A, business sales and acquisitions, restructures, securities regulatory and ASX compliance issues, ESOPs and other general corporate matters.

She regularly acts for companies and investors in the healthcare and biotechnology sector, as well as the technology industry more broadly.

Capital markets

  • Visioneering Technologies, Inc.– advised on its A$33.3 million IPO and ASX listing in March 2017.
  • AirXpanders, Inc. - advised on its A$36.5 million IPO and ASX listing in 2015 and its follow-on capital raisings in 2016 and 2017.
  • Osprey Medical, Inc.– advised on its private placement of CDIs and Security Purchase Plan in 2016.
  • ImpediMed Limited– advised on A$75 million placement and Share Purchase Plan in 2016.
  • TrailStone Group – advised on its investment in ASX-listed Southern Cross Goldfields in November 2014.
  • BSA Limited – advised on its underwritten entitlement offer in 2014.

Venture capital

  • Cardiac Dimensions– advised on its bridge financing in 2017.
  • Juniper Networks– advised on its investment in OneConfig in 2016.
  • MH Carnegie– advised on its investment in Renew Medical in 2016.
  • Freestyle – advised on its investment in RangeMe and related redomicile in 2015.
  • Arboretum Ventures– advised on its investment in Cardiac Dimensions in 2014.
  • Novo A/S– advised on its Series C investment in Spinifex Pharmaceuticals and Spinifex’s related redomicile in 2014.

Mergers, acquisitions and restructures

  • Blackmores Limited– advised on infant formula joint venture with Bega Cheese in 2016.
  • EnGeneIC Limited– advised on redomicile to Bermuda via scheme of arrangement in 2015.
  • Calera Capital – acted as Australian counsel on acquisition of Transaction Services Group in 2015.
  • Archer Capital – advised on acquisition of the LCR Group in 2014.
  • Unitrends Software– advised on acquisition of Yuruware in 2014.
  • Microsoft– acted as Australian counsel on the acquisition of Nokia Australia 2014.


  • 2XU– advised on implementation of its management incentive plan.
  • RM Williams– advised on implementation of its management incentive plan.
  • Various ASX-listed companies (Blackmores Limited, AirXpanders, Inc., Visioneering Technologies, Inc. and ImpediMed Limited)– advice on equity incentive plans.


  • Bachelor of Laws, University of Wollongong
  • Bachelor of Arts, University of Wollongong


  • Law Society of New South Wales
  • Law Society of South Australia

International experience

  • Clare has significant experience advising US clients doing business in Australia and Australian clients doing business in the US, including having acted for a number of US med-tech companies on their proposed Australian IPOs and ASX-listings.